You have read all your free articles, to continue reading subscribe to read the rest of this content.
The U.S. Biomedical Advanced Research and Development Authority (BARDA) have exercised another option under the ongoing contract for freeze-dried MVA-BN smallpox vaccine. The option, valued at USD 44 million, will cover qualification of the new fill-finish facility, currently being established atAlready a subscriber Login You have read all your free…
AstraZeneca and Merck & Co announced that the US Food and Drug Administration (FDA) has granted approval for the PARP inhibitor, Lynparza (olaparib). The approval is as follows: New use of Lynparza as a maintenance treatment for recurrent, epithelial ovarian, fallopian tube or primarAlready a subscriber Login You have read all your free articles,…
BioInvent International has restructured a clinical development agreement with Cancer Research UK (CRUK) for its anti-FcγRIIB antibody, BI-1206. In exchange for a one-time payment, the revised deal simplifies and reduces BioInvent’s obligations to CRUK, which provides BioInvent with more flexiAlready a subscriber Login You have read all your free articles,…
The global big pharma company Bayer has decided to move its Swedish operations to the Karolinska Institute Campus in Solna and it has also entered collaborations with Norrsken Foundation. According to Maria Rankka, CEO of the Swedish Chamber of Commerce, the move to the Karolinska Institute CampuAlready a subscriber Login…
